Ardea Biosciences, Inc. (RDEA) Posts Q2 Loss of 68c, Wider than Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q2 loss of ($0.68), $0.16 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.69 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ManpowerGroup (MAN) Reports In-Line Q3 EPS; offers guidance
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
- Johnson & Johnson (JNJ) Tops Q3 EPS by 6c; adjusts forecast
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
